IL-13 secreted by ILC2 can induce epithelial cell SATA6 activation, which affects gut permeability and exacerbates experimental colitis, and STAT6 inhibition can reverse epithelial apoptosis and claudin-2 expression (20). Here, IL13 is linked to colitis.